Saskatchewan Wholesale Trade Growth Leads Nation

Jan 22, 2021

Saskatchewan’s wholesale trade was up 21.5 per cent (seasonally adjusted) in November 2020 when compared to November 2019, the highest percentage increase among the provinces. The value of Saskatchewan’s wholesale trade in November 2020 was $2.46 billion.

“A 21.5 per cent increase over the past year in wholesale trade is a remarkable statistic given the global Covid-19 pandemic,” Trade and Export Development Minister Jeremy Harrison said. “Wholesale trade is an important leading indicator and shows that our province is very well positioned for a strong economic recovery.”

In today’s Statistics Canada report, wholesale trade in Saskatchewan was up 2.6 per cent on a month-over-month basis, the second highest percentage change among provinces. Nationally, trade was up 0.7 per cent month-over-month and 7.7 per cent year-over-year.

Growth in wholesale trade was reported in several sectors, including food and beverage merchant wholesalers; machinery, equipment and supplies merchant wholesalers; and, motor vehicle and motor vehicle parts and accessories merchant wholesalers.

Click here to see more...

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.